{"entity":{"type":"insider","cik":"0001927648","url":"/insider/0001927648","json_url":"/insider/0001927648.json","name":"Burkhart Erin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2024-04-12","last":"2025-05-20","span_basis":"filed_date"},"name_variants":[{"name":"Burkhart Erin","source":"filing","n_filings":5,"first_seen":"2024-04-12","last_seen":"2025-05-20"}],"transactions":[{"id":4793871,"accession":"0001048477-25-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001048477-25-000060","line_url":"/filing/0001048477-25-000060#line-2","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001927648","owner_name":"Burkhart Erin","owner_display_name":"Burkhart Erin","owner_url":"/insider/0001927648","role":"Officer (GVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (GVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1786.0,"shares_display":"1,786","price_per_share":59.31,"price_display":"59.31","price_state":"stated","total_value":105927.66,"total_display":"105,927.66","total_whole":"105,928","shares_owned_after":14173.0,"shares_owned_after_display":"14,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-20","scope":"insider"},{"id":4246879,"accession":"0001048477-25-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-25-000041","line_url":"/filing/0001048477-25-000041#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001927648","owner_name":"Burkhart Erin","owner_display_name":"Burkhart Erin","owner_url":"/insider/0001927648","role":"Officer (GVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (GVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1295.0,"shares_display":"1,295","price_per_share":71.52,"price_display":"71.52","price_state":"stated","total_value":92618.4,"total_display":"92,618.40","total_whole":"92,618","shares_owned_after":16955.0,"shares_owned_after_display":"16,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":4874108,"accession":"0001048477-25-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-25-000009","line_url":"/filing/0001048477-25-000009#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001927648","owner_name":"Burkhart Erin","owner_display_name":"Burkhart Erin","owner_url":"/insider/0001927648","role":"Officer (GVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (GVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1344.0,"shares_display":"1,344","price_per_share":68.38,"price_display":"68.38","price_state":"stated","total_value":91902.72,"total_display":"91,902.72","total_whole":"91,903","shares_owned_after":13105.0,"shares_owned_after_display":"13,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":2040880,"accession":"0001048477-24-000128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-24-000128","line_url":"/filing/0001048477-24-000128#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001927648","owner_name":"Burkhart Erin","owner_display_name":"Burkhart Erin","owner_url":"/insider/0001927648","role":"Officer (GVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (GVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":714.0,"shares_display":"714","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":64260.0,"total_display":"64,260.00","total_whole":"64,260","shares_owned_after":14449.0,"shares_owned_after_display":"14,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":3037502,"accession":"0001048477-24-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001048477-24-000061","line_url":"/filing/0001048477-24-000061#line-1","is_derivative":false,"issuer_cik":"0001048477","issuer_name":"BIOMARIN PHARMACEUTICAL INC","issuer_ticker":"BMRN","issuer_name_source":null,"issuer_url":"/issuer/0001048477","owner_cik":"0001927648","owner_name":"Burkhart Erin","owner_display_name":"Burkhart Erin","owner_url":"/insider/0001927648","role":"Officer (GVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (GVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GVP, Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2286.0,"shares_display":"2,286","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":205740.0,"total_display":"205,740.00","total_whole":"205,740","shares_owned_after":16156.0,"shares_owned_after_display":"16,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001048477","name":"BIOMARIN PHARMACEUTICAL INC","url":"/issuer/0001048477","role":"Officer (GVP, Chief Accounting Officer)","n_filings":5,"first_seen":"2024-04-12","last_seen":"2025-05-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001927648","retrieved_at":"2026-08-27T07:11:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}